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Background
It is still controversy in thalassemia major (TM) if Cardiovascular Magnetic Resonance (CMR) T2* screening should be initiated before the 10 years. To answer this question, we studied retrospectively the prevalence of cardiac iron and function and myocardial fibrosis by CMR in a consistent cohort of TM patients younger than 10 years.
Methods
From the 2171 patients enrolled in the MIOT (Myocardial Iron Overload in Thalassemia) network, we retrospectively selected the 35 TM patients aged less than 10 years who had undergone at least one MRI scan. Myocardial iron overload (MIO) was measured by T2* multislice multiecho technique. Biventricular function parameters were quantitatively evaluated in a standard way by cine images. To detect myocardial fibrosis, late gadolinium enhancement images were acquired.
Results
Patients' age ranged from 4.2 to 9.7 years. All MRI scans were performed without sedation. Nine patients (25.7%) showed no myocardial iron overload (MIO), 22 patients (62.9%) showed an heterogeneous MIO with a T2* global value ≥ 20 ms; 2 patients (5.7%) showed an heterogeneous MIO and a T2* global value < 20 ms and 2 patients (5.7%) had a homogeneous MIO (Figure 1 ). Biventricular function parameters were assessed only in 28/35 patients (80%), because for 7 patients a short MRI protocol was chosen to avoid sedation. LV dysfunction (EF < 54%) was found in one patient (male, 7-year old, treated with deferoxamine and showing an heterogeneous myocardial iron overload with a global T2* value = 31.1 ms). No patient showed RV dysfunction. Finally, 14 patients completed the MRI protocol with acquisition of the LGE images and none of them showed myocardial fibrosis. Table 1 reports the data of the 4 patients (3 males and 1 female) with significant myocardial iron overload (global heart T2* < 20 ms). The youngest patient was 6 years old, all patient showed no heart dysfunction and in all the iron transfused was less than 35 g.
Conclusions
The first cardiac T2* assessment should be performed as early as possible without sedation and it is mandatory whenever poor compliance is suspected or if chelation has been started late.
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